arrow
R

Rodrigo Fresco

Fred Hutchinson Cancer Center
H指数:12
被引数:1,965

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

STEEP criteria v2.0 validation: A multi- trial analysis using GEICAM and TRIO adjuvant trials to evaluate surrogate endpoints for overall survival
2024-05-020
PRE
Ribociclib plus Endocrine Therapy in Early Breast Cancer
2024-03-2156
PRE
Invasive diseaseefree survival (iDFS) across key subgroups from the phase III NATALEE study of ribociclib (RIB) plus a nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HRD/HER2-early breast cancer (EBC)
2023-10-013
PRE
Health-related quality of life (HRQoL) in the phase III NATALEE study of adjuvant ribociclib (RIB) plus a nonsteroidal aromatase inhibitor (NSAI) vs NSAI alone in patients (pts) with HRD/HER2-early breast cancer (EBC)
2023-10-011
OAAI
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR+/HER2-early breast cancer

NATALEE的基本原理和试验设计: 在HR /HER2-early乳腺癌患者中,辅助ribociclib加内分泌治疗与单独内分泌治疗的III期试验

2023-05-2940
OAAI
Planning cancer control in Latin America and the Caribbean
2013-04-01369
PREAI